Google Übersetzer
Basilea Pharmaceutica Ag
About
Basilea Pharmaceutica Ag — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 15 2026
Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting
Apr 9 2026
Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420
Mar 23 2026
Basilea announces start of first‑in‑human study of novel antibiotic BAL2420
Feb 25 2026
Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
Feb 17 2026
Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance
Recent Videos
Pharma and AI Partnering to Drive Potential New Era in Antibiotic Development
Apr 14, 2026
Basilea Pharmaceutica Q4 2025 Earnings Call
Feb 18, 2026
BSLN STOCK : READY FOR RECOVERY | BASILEA PHARMACEUTICA STOCK
Jan 24, 2026
118. Bull, Bear & Beyond – Basilea Pharmaceutica executive interview
Jan 09, 2026